ID: ALA4169570

Max Phase: Preclinical

Molecular Formula: C19H11Cl3N2O

Molecular Weight: 389.67

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1nc(-c2ccc(Cl)cc2)cc(-c2ccc(Cl)cc2Cl)c1C#N

Standard InChI:  InChI=1S/C19H11Cl3N2O/c1-25-19-16(10-23)15(14-7-6-13(21)8-17(14)22)9-18(24-19)11-2-4-12(20)5-3-11/h2-9H,1H3

Standard InChI Key:  DMIFJPDBLQMZHA-UHFFFAOYSA-N

Associated Targets(non-human)

Trachea 112 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 389.67Molecular Weight (Monoisotopic): 387.9937AlogP: 6.26#Rotatable Bonds: 3
Polar Surface Area: 45.91Molecular Species: NEUTRALHBA: 3HBD: 0
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 6.54CX LogD: 6.54
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.53Np Likeness Score: -1.40

References

1. Soliman EA, Panda SS, Aziz MN, Shalaby EM, Mishriky N, Asaad FM, Girgis AS..  (2017)  Synthesis, molecular modeling studies and bronchodilation properties of nicotinonitrile containing-compounds.,  138  [PMID:28753516] [10.1016/j.ejmech.2017.07.025]

Source